Purple Biotech Ltd. (PPBT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Purple Biotech Ltd.

    NASDAQ: PPBT · Real-Time Price · USD
    0.64
    -0.14 (-17.95%)
    At close: Sep 05, 2025, 3:59 PM
    0.65
    1.56%
    After-hours: Sep 05, 2025, 07:49 PM EDT

    Purple Biotech Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 195.8K n/a n/a
    Cost of Revenue
    		 186K 196K 120.00 55.00
    Gross Profit
    		 -186K -196 -120 -55
    Operating Income
    		 -11.01M -22.27M -22.6M -17.93M
    Interest Income
    		 260K 474K 532K 320K
    Pretax Income
    		 -7.28M -19.98M -21.76M -17.83M
    Net Income
    		 -7.24M -19.88K -21.67M -18.38M
    Selling & General & Admin
    		 2.94M 4.84M 5.96M 5.82M
    Research & Development
    		 7.62M 17.03M 16.32M 11.83M
    Other Expenses
    		 450K 393K 321K 12K
    Operating Expenses
    		 11.01M -22.47M 22.6M 17.93M
    Interest Expense
    		 447K 2.18M 67K 212K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 11.01M 22.27M 22.6M 17.93M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 2.59M 1.23M 924.08K 890K
    Shares Outstanding (Diluted)
    		 2.59M 1.23M 924.08K 890K
    EPS (Basic)
    		 -4.42 -0.16 -0.23 -0.21
    EPS (Diluted)
    		 -4.42 -0.16 -0.23 -0.21
    EBITDA
    		 -7.05M -22.23M -21.49M -17.52M
    EBIT
    		 -7.24M -19.92M -21.69M -17.75M
    Depreciation & Amortization
    		 186K 46K 201K 231K

    Add to Watchlist